581 related articles for article (PubMed ID: 23455361)
1. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups.
Manes A; Palazzini M; Leci E; Bacchi Reggiani ML; Branzi A; Galiè N
Eur Heart J; 2014 Mar; 35(11):716-24. PubMed ID: 23455361
[TBL] [Abstract][Full Text] [Related]
2. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
3. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
4. Contemporary survival of patients with pulmonary arterial hypertension and congenital systemic to pulmonary shunts.
Vijarnsorn C; Durongpisitkul K; Chungsomprasong P; Bositthipichet D; Ketsara S; Titaram Y; Chanthong P; Kanjanauthai S; Soongswang J
PLoS One; 2018; 13(4):e0195092. PubMed ID: 29664959
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
[TBL] [Abstract][Full Text] [Related]
6. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
[TBL] [Abstract][Full Text] [Related]
7. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects.
Sitbon O; Beghetti M; Petit J; Iserin L; Humbert M; Gressin V; Simonneau G
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():25-31. PubMed ID: 16919007
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension in adults with congenital heart disease and Eisenmenger syndrome: current advanced management strategies.
D'Alto M; Diller GP
Heart; 2014 Sep; 100(17):1322-8. PubMed ID: 24829371
[TBL] [Abstract][Full Text] [Related]
9. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria.
Douwes JM; van Loon RL; Hoendermis ES; Vonk-Noordegraaf A; Roofthooft MT; Talsma MD; Hillege HL; Berger RM
Eur Heart J; 2011 Dec; 32(24):3137-46. PubMed ID: 21893489
[TBL] [Abstract][Full Text] [Related]
10. Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study.
Hascoet S; Fournier E; Jaïs X; Le Gloan L; Dauphin C; Houeijeh A; Godart F; Iriart X; Richard A; Radojevic J; Amedro P; Bosser G; Souletie N; Bernard Y; Moceri P; Bouvaist H; Mauran P; Barre E; Basquin A; Karsenty C; Bonnet D; Iserin L; Sitbon O; Petit J; Fadel E; Humbert M; Ladouceur M
Arch Cardiovasc Dis; 2017 May; 110(5):303-316. PubMed ID: 28286190
[TBL] [Abstract][Full Text] [Related]
11. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value.
Scognamiglio G; Kempny A; Price LC; Alonso-Gonzalez R; Marino P; Swan L; D' Alto M; Hooper J; Gatzoulis MA; Dimopoulos K; Wort SJ
Heart; 2014 Sep; 100(17):1335-41. PubMed ID: 24790070
[TBL] [Abstract][Full Text] [Related]
13. Congenital heart disease-associated pulmonary arterial hypertension: preliminary results from a novel registry.
Rose ML; Strange G; King I; Arnup S; Vidmar S; O'Donnell C; Kermeen F; Grigg L; Weintraub RG; Celermajer DS
Intern Med J; 2012 Aug; 42(8):874-9. PubMed ID: 22212153
[TBL] [Abstract][Full Text] [Related]
14. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005.
van Loon RL; Roofthooft MT; Hillege HL; ten Harkel AD; van Osch-Gevers M; Delhaas T; Kapusta L; Strengers JL; Rammeloo L; Clur SA; Mulder BJ; Berger RM
Circulation; 2011 Oct; 124(16):1755-64. PubMed ID: 21947294
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Pulmonary Artery Compliance in Patients with Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease.
Cheng XL; Liu ZH; Gu Q; Ni XH; Luo Q; Zhao ZH; He JG; Xiong CM
Int Heart J; 2017 Oct; 58(5):731-738. PubMed ID: 28966315
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy.
D'Alto M; Romeo E; Argiento P; Santoro G; Sarubbi B; Gaio G; Mélot C; Russo MG; Naeije R; Calabrò R
Heart; 2010 Sep; 96(18):1475-9. PubMed ID: 20668108
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease.
Durongpisitkul K; Jakrapanichakul D; Sompradikul S
J Med Assoc Thai; 2008 Feb; 91(2):196-202. PubMed ID: 18389984
[TBL] [Abstract][Full Text] [Related]
18. Endothelin receptor antagonists are an effective long term treatment option in pulmonary arterial hypertension associated with congenital heart disease with or without trisomy 21.
Kermeen FD; Franks C; O'Brien K; Seale H; Hall K; McNeil K; Radford D
Heart Lung Circ; 2010 Oct; 19(10):595-600. PubMed ID: 20728407
[TBL] [Abstract][Full Text] [Related]
19. Survival in patients with pulmonary arterial hypertension treated with first-line bosentan.
McLaughlin VV
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():10-5. PubMed ID: 16919005
[TBL] [Abstract][Full Text] [Related]
20. Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome.
D'Alto M; Romeo E; Argiento P; D'Andrea A; Sarubbi B; Correra A; Scognamiglio G; Papa S; Bossone E; Calabrò R; Vizza CD; Russo MG
Int J Cardiol; 2013 Apr; 164(3):323-6. PubMed ID: 21802156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]